CCDC33: Potential Drug Target and Biomarker (G80125)

Target Name: CCDC33

NCBI ID: G80125

CCDC33

CCDC33: Potential Drug Target and Biomarker

CCDC33 (Complement Component 33) is a protein that is expressed in a variety of tissues throughout the body, including the liver, spleen, and lungs. It is a key component of the complement system, which is a group of proteins that work together to help the immune system fight off infections.

One of the things that makes CCDC33 an interesting potential drug target is its role in the development of certain diseases. For example, CCDC33 has been shown to be involved in the development of liver cancer, and may also be a useful biomarker for this disease.

Another potential use for CCDC33 as a drug target is its role in the treatment of autoimmune disorders. For example, CCDC33 has been shown to play a role in the development of rheumatoid arthritis, and may be a useful target for new treatments for this disease.

In addition to its potential use as a drug target, CCDC33 is also a potential biomarker for a variety of diseases. For example, it has been shown to be elevated in the blood of people with a variety of liver diseases, including hepatitis C and nonalcoholic steatohepatitis (NASH). This suggests that CCDC33 may be a useful indicator of the severity of these diseases and could be used to track the effectiveness of certain treatments.

CDC33 is also a potential target for new therapies for other diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that inhibiting CCDC33 can be an effective way to treat certain types of cancer, such as melanoma and cervical cancer.

In addition to its potential use as a drug target and biomarker, CCDC33 is also a complex protein that is involved in a variety of physiological processes in the body. For example, it is involved in the immune response and works with other proteins in the complement system to help the body fight off infections.

Overall, CCDC33 is a protein that has the potential to be a drug target and biomarker for a variety of diseases. Further research is needed to fully understand its role in the immune system and its potential as a therapeutic target.

Protein Name: Coiled-coil Domain Containing 33

The "CCDC33 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC33 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets